Webinar

Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics

T cell exhaustion is recognized as a major challenge in the development of immuno-oncology therapies. It describes the loss of effector function due to chronic antigen exposure, and often occurs within the tumor microenvironment, impairing the ability of T cells to eradicate cancerous cells effectively.

The development of tumor-specific immunotherapies focuses on overcoming this exhausted phenotype of T cells, to allow targeted killing of the tumor.

Attend this expert webinar to:

  • Gain unique insights into how bispecific T cell engager (BiTE) antibodies in an immune cell killing assay affect T cell exhaustion
  • Explore the influence of target cells on CAR-T cell exhaustion
  • Learn how to use an advanced flow cytometry platform to quantify T cell exhaustion phenotypes and cytokine release

Who should attend?

Immuno-oncology, cancer immunotherapy drug discovery and immunology researchers in pharma, biopharma and academia.

Links